- Home
-
- Uncategorized
-
- Breakthrough Cell Therapy Restores Insulin in Type 1 Diabetes Patient
Breakthrough Cell Therapy Restores Insulin in Type 1 Diabetes Patient
Quick Summary
- Researchers have developed a therapy for Type 1 diabetes using genetically modified insulin-producing cells that evade immune system attacks, possibly eliminating the need for immunosuppressants.
- A groundbreaking case involved a 42-year-old diabetic patient who received nearly 80 million modified pancreatic beta cells injected into his arm. After three months, the cells survived, produced insulin, and avoided immune system rejection.
- The therapy employs CRISPR gene-editing to remove immune-response markers and enhance anti-rejection genes in donor cells.
- Early results show slight improvements in natural insulin production post-transplantation; however, the patient still requires external insulin supplementation as the transplanted cells only provided about 7% of his total needs.
- Scientists are optimistic but caution that safety and efficacy must be confirmed through long-term monitoring and larger trials beyond this single participant study before wider usage is approved.
!Read More
0 Votes: 0 Upvotes, 0 Downvotes (0 Points)
Stay Informed With the Latest & Most Important News